Service providers operating outside the traditional sectors of automotive, industry and insurance are becoming increasingly important for the German economy. To reflect this development, the DAX will be expanded from 30 to 40 stocks on September 20. The leading German index will now include not only established major corporations but also innovative, high-growth companies. With the expansion, 80% of the market value of the German stock market will be covered in the future (before the adjustment, the coverage is approximately two-thirds).
The new index members come from various sectors and industries and are therefore broadly diversified:
+29% YTD: Airbus (aircraft manufacturer)
+35% YTD: Brenntag (world's largest chemical distributor)
+45% YTD: Hellofresh (cooking box shipper)
+53% YTD: Porsche (car manufacturer)
+14% YTD: Puma (sporting goods manufacturer)
+11% YTD: Qiagen (diagnostics and biotechnology company)
+71% YTD: Sartorius (pharmaceutical supplier)
+36% YTD: Siemens Healthineers (medical technology)
+11% YTD: Symrise (fragrance and flavor manufacturer)
+7% YTD: Zalando (online fashion retailer)
Inclusion in the DAX should bring more investor attention to the new stocks. Investors can participate in this development with tracker certificates from Zürcher Kantonalbank:
Tracker certificate on the index advancers (EUR / CHF)
The initial fixing of our tracker certificate will take place at the close of trading on September 15 and thus 3 trading days before the index adjustment, which must also be completed by physical replicated ETFs.
Disclaimer
This communication is for marketing purposes. It is neither an offer nor an invitation to submit an offer, to purchase or to subscribe to securities and does not constitute investment advice. You should consult your advisors before making an investment decision.
Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, financial condition, development or performance of the issuer to be materially different from any future results, financial condition, development or performance expressed or implied by such statements.
The present document has not been drawn up by the research department as defined in the rules of the “Directives on the Independence of Financial Research” published by the Swiss Bankers Association, hence these rules do not apply to this document.
If securities are mentioned in the communication, the base prospectus, the final terms and any key information document may be obtained free of charge from Zürcher Kantonalbank, Bahnhofstrasse 9, 8001 Zurich, VRIS, and from www.zkb.ch/finanzinformationen.
ZKB Barrier Reverse Convertible mit bedingtem Coupon on worst of Salesforce.com Inc/NVIDIA Corp/Supe... 132913957 / CH1329139575 |
ZKB Autocallable Barrier Reverse Convertible on worst of Biogen Inc/BioNTech SE/Moderna Inc 132913422 / CH1329134220 |
ZKB Reverse Convertible auf Moderna Inc 135805537 / CH1358055379 |
22.09% ZKB Reverse Convertible, 16.01.2025 on worst of NVDA UW/TSLA UW/MRNA UW NVIDIA Corp/Tesla Inc... 130398418 / CH1303984186 |
11.17% ZKB Reverse Convertible, 03.03.2025 on worst of QCOM UW/AAL UW/MRNA UW Qualcomm Inc/American ... 135805027 / CH1358050271 |